Platelet and liver regeneration after liver surgery.
Allografts
Benzoates
/ administration & dosage
Blood Platelets
/ metabolism
Cell Proliferation
/ drug effects
Hepatectomy
Hepatocyte Growth Factor
/ metabolism
Hepatocytes
/ physiology
Humans
Hydrazines
/ administration & dosage
Insulin-Like Growth Factor I
/ metabolism
Liver Failure
/ drug therapy
Liver Regeneration
/ drug effects
Liver Transplantation
Platelet Transfusion
Postoperative Complications
/ drug therapy
Primary Graft Dysfunction
/ drug therapy
Pyrazoles
/ administration & dosage
Receptors, Thrombopoietin
/ agonists
Treatment Outcome
Vascular Endothelial Growth Factor A
/ metabolism
Growth factors
Hepatectomy
Liver regeneration
Platelets
Journal
Surgery today
ISSN: 1436-2813
Titre abrégé: Surg Today
Pays: Japan
ID NLM: 9204360
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
18
03
2019
accepted:
03
08
2019
pubmed:
14
11
2019
medline:
31
10
2020
entrez:
14
11
2019
Statut:
ppublish
Résumé
The success of liver surgery, including resection and transplantation, is largely dependent on the ability of the liver to regenerate. Despite substantial improvement in surgical techniques and perioperative care, one of the main concerns is post-hepatectomy liver failure and early allograft dysfunction, both of which are associated with impaired liver regeneration. Recent studies have demonstrated the positive role of platelets in promoting liver regeneration and protecting hepatocytes; however, the underlying mechanisms responsible for these effects are not fully understood. In this review, we updated the accumulated evidence of the role of platelets in promoting liver regeneration, with a focus on liver resection and liver transplantation. The goal of these studies was to support the clinical implementation of platelet agents, such as thrombopoietin receptor agonists, to augment liver regeneration after liver surgery. This "platelet therapy" may become a treatment choice for post-hepatectomy liver failure and early allograft dysfunction.
Identifiants
pubmed: 31720801
doi: 10.1007/s00595-019-01890-x
pii: 10.1007/s00595-019-01890-x
doi:
Substances chimiques
Benzoates
0
HGF protein, human
0
Hydrazines
0
Pyrazoles
0
Receptors, Thrombopoietin
0
Vascular Endothelial Growth Factor A
0
Hepatocyte Growth Factor
67256-21-7
Insulin-Like Growth Factor I
67763-96-6
eltrombopag
S56D65XJ9G
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM